TET2 in Normal and Malignant Hematopoiesis

Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):a026518. doi: 10.1101/cshperspect.a026518.

Abstract

The ten-eleven translocation (TET) family of enzymes were originally cloned from the translocation breakpoint of t(10;11) in infant acute myeloid leukemia (AML) with subsequent genomic analyses revealing somatic mutations and suppressed expression of TET family members across a range of malignancies, particularly enriched in hematological neoplasms. The TET family of enzymes is responsible for the hydroxylation of 5-methylcytosines (5-mC) to 5-hydroxymethylcytosine (5-hmC), followed by active and passive mechanisms leading to DNA demethylation. Given the complexity and importance of DNA methylation events in cellular proliferation and differentiation, it comes as no surprise that the TET family of enzymes is intricately regulated by both small molecules and regulatory cooperating proteins. Here, we review the structure and function of TET2, its interactions with cooperating mutations and small molecules, and its role in aberrant hematopoiesis.

Publication types

  • Review

MeSH terms

  • 5-Methylcytosine / metabolism
  • Cell Differentiation
  • DNA Methylation*
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / physiology*
  • Dioxygenases
  • Epigenesis, Genetic*
  • Gene Expression Regulation, Neoplastic
  • Hematologic Neoplasms / genetics*
  • Hematologic Neoplasms / metabolism
  • Hematopoiesis / genetics*
  • Humans
  • Mutation
  • Oxidation-Reduction
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins / physiology*

Substances

  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • 5-Methylcytosine
  • Dioxygenases
  • TET2 protein, human